ClinicalTrials.Veeva

Menu

Cardiovascular Health And Risk Modification in Family Health Teams (Multi-CHARM)

U

University of Toronto

Status and phase

Completed
Phase 3

Conditions

Hypertension
Diabetes
Hyperlipidemia
Cardiovascular Risk Factors

Treatments

Behavioral: Active risk factor surveillance

Study type

Interventional

Funder types

Other

Identifiers

NCT00787306
MOH-1048

Details and patient eligibility

About

Cardiovascular diseases remain the main cause of mortality in Canada. While effective interventions are available for reducing the risk of cardiovascular disease,there continue to be gaps between the potential reduction in risk that could be achieved by effectively managing these risk factors and levels of risk factor control currently in clinical practice. This study will evaluate the ability of a different model of risk factor care using other health providers assisting family doctors, along with information aids for patients and health professionals,to achieve better levels of cardiovascular risk factor control in adults.

Enrollment

229 patients

Sex

All

Ages

50 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adults 50 to 80 years of age
  • having attending a family medicine clinic for more than one year

Exclusion criteria

  • not able to participate for one year
  • not able to read English
  • requires house calls
  • nursing home resident
  • cognitive impairment
  • current chest pain or symptoms of active coronary heart disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

229 participants in 2 patient groups

Multi-faceted Cardiovascular Decision Support
Experimental group
Description:
Risk factor active surveillance, multi-disciplinary disease management and decision aid intervention
Treatment:
Behavioral: Active risk factor surveillance
Control Usual Care
Other group
Description:
Usual care in a wait-list control arm that receives the experimental intervention after 6 months.
Treatment:
Behavioral: Active risk factor surveillance

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems